Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tian An MedicareCOLRF 43 EV-to-EBIT is 46.80 as of Jul. 31, 2026, which is 599% above its 10-year median of 6.70. GuruFocus rates COLRF with a GF Score™ of 43/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Tian An Medicare ranks worse than 86.62% on this metric.
Tian An Medicare (OTCPK:COLRF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Tian An Medicare's Enterprise Value for the quarter that ended in Dec. 2025 was $112.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tian An Medicare's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $2.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tian An Medicare EV-to-EBIT Related Terms
Tian An Medicare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Tian An Medicare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Tian An Medicare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tian An Medicare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Tian An Medicare's EV-to-EBIT falls into.
Tian An Medicare's current Enterprise Value is $129.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tian An Medicare's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $2.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tian An Medicare (COLRF) has a EV-to-EBIT of 46.80 as of Jul. 31, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Tian An Medicare and its competitors. This is 599% above median its historical median of 6.70. According to the industry distribution chart, Tian An Medicare ranks #408 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 86.6%.
Is Tian An Medicare's EV-to-EBIT too high?
Tian An Medicare's current EV-to-EBIT of 46.80 is 599% above median its 10-year median of 6.70. The Healthcare Providers & Services industry median EV-to-EBIT is 15.84. Tian An Medicare's value of 46.80 is 195.5% above this industry median. Based on the distribution chart, Tian An Medicare ranks #408 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Tian An Medicare has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #408 out of 471 companies for EV-to-EBIT. This places Tian An Medicare in the lower half of its industry. The industry median EV-to-EBIT is 15.84. Tian An Medicare's value of 46.80 is 195.5% above this benchmark. While the company's 10-year median is 6.70 vs. the industry median of 15.84, Tian An Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.84, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tian An Medicare's current EV-to-EBIT of 46.80 is 195.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Tian An Medicare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tian An Medicare's current EV-to-EBIT is 46.80, which is 599% above median its own 10-year median of 6.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current EV-to-EBIT of 46.80. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current EV-to-EBIT is 46.80, which is 599% above median its 10-year median of 6.70 and 195.5% above the Healthcare Providers & Services industry median of 15.84. Tian An Medicare's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current EV-to-EBIT is 46.80 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tian An Medicare (COLRF) Overvalued in 2026?
Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued.
The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.
Key valuation signals for COLRF:
EV-to-EBIT: 46.80 (599% above median its 10-year median of 6.70)
GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
Industry Position: 195.5% above the Healthcare Providers & Services median (#408 of 471)
No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
43GF Score
Get the complete analysis for COLRF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COLRF has been successfully added to your 
